Search research articles
Contact Us
Filters
Showing results (111-120 of 165) with videos related to
Page
of 17
Sort By:
Chemmedchem
|
December 7, 2020
Systematic Assessment of Fragment Identification for Multitarget Drug Design
Steffen Brunst, Jan S Kramer, Whitney Kilu, et al.
Chemmedchem
|
September 23, 2024
We are MedChem: The Frontiers in Medicinal Chemistry 2024
Matthias Schiedel, Philipp Barbie, Felix Pape, et al.
Journal of Medicinal Chemistry
|
May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications
Jan Vietor, Christian Gege, Tanja Stiller, et al.
Journal of Medicinal Chemistry
|
June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene Expression
Emily C Hank, Romy Busch, Úrsula López-García, et al.
Scientific Reports
|
May 3, 2018
Allosteric modulation of the farnesoid X receptor by a small molecule
Matthias Gabler, Jan Kramer, Jurema Schmidt, et al.
Cell Chemical Biology
|
May 14, 2021
Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactions
Sabine Willems, Leonie Gellrich, Apirat Chaikuad, et al.
Journal of Medicinal Chemistry
|
February 1, 2019
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation
Julius Pollinger, Leonie Gellrich, Simone Schierle, et al.
Journal of Medicinal Chemistry
|
September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole
Minh Sai, Jan Vietor, Moritz Kornmayer, et al.
Communications Chemistry
|
January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice
Pascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.
Bioorganic & Medicinal Chemistry
|
April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 165) with videos related to
Sort By:
Page
of 17
Chemmedchem
|
December 7, 2020
Systematic Assessment of Fragment Identification for Multitarget Drug Design
Steffen Brunst, Jan S Kramer, Whitney Kilu, et al.
Chemmedchem
|
September 23, 2024
We are MedChem: The Frontiers in Medicinal Chemistry 2024
Matthias Schiedel, Philipp Barbie, Felix Pape, et al.
Journal of Medicinal Chemistry
|
May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications
Jan Vietor, Christian Gege, Tanja Stiller, et al.
Journal of Medicinal Chemistry
|
June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene Expression
Emily C Hank, Romy Busch, Úrsula López-García, et al.
Scientific Reports
|
May 3, 2018
Allosteric modulation of the farnesoid X receptor by a small molecule
Matthias Gabler, Jan Kramer, Jurema Schmidt, et al.
Cell Chemical Biology
|
May 14, 2021
Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactions
Sabine Willems, Leonie Gellrich, Apirat Chaikuad, et al.
Journal of Medicinal Chemistry
|
February 1, 2019
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation
Julius Pollinger, Leonie Gellrich, Simone Schierle, et al.
Journal of Medicinal Chemistry
|
September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole
Minh Sai, Jan Vietor, Moritz Kornmayer, et al.
Communications Chemistry
|
January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice
Pascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.
Bioorganic & Medicinal Chemistry
|
April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.
Page
of 17